Daniel Bar-Shalom is an Associate Professor in the Department of Pharmacy, specializing in Physiological Pharmaceutics at the University of Copenhagen. He is based at Universitetsparken 2, 2100 København Ø, and can be reached at daniel.barshalom@sund.ku.dk or by phone at +4535336351. Dr. Bar-Shalom's research focuses on advanced drug delivery systems and pharmaceutical formulations. His work spans several key areas including: Nanoparticle-based drug delivery systems Amorphous solid dispersions for improved drug solubility Self-nanoemulsifying drug delivery systems (SNEDDS) pH-independent controlled release formulations Physiological aspects of drug absorption and dissolution Novel excipients for complex drug delivery challenges Analysis of Dr. Bar-Shalom's recent publications reveals a strong focus on innovative drug delivery technologies that address specific pharmaceutical challenges. His work demonstrates expertise in both experimental formulation development and computational modeling approaches. The research spans from fundamental physicochemical characterization to clinically relevant delivery systems, with particular attention to challenging drug molecules like amphotericin B and celecoxib. Recent work shows increasing sophistication in combining multiple technologies to create multifunctional delivery systems that overcome specific biological barriers. Dr. Bar-Shalom has made significant contributions to the field of pharmaceutical sciences through his research on advanced drug delivery systems. While specific awards are not mentioned in the available information, his work has garnered attention as evidenced by social media mentions and reader engagement across multiple platforms. As an Associate Professor, Dr. Bar-Shalom is involved in mentoring students and researchers in the field of pharmaceutical sciences. His collaborative approach is evident from the multiple co-authorships across different institutions. His research program appears to be well-funded, supporting investigations into novel drug delivery technologies with potential clinical applications. Dr. Bar-Shalom is part of the Physiological Pharmaceutics research group within the Department of Pharmacy at the University of Copenhagen. This team focuses on understanding the interplay between drug formulations and physiological factors that affect drug absorption and performance. The group employs both experimental and computational approaches to develop advanced pharmaceutical products with improved efficacy and patient compliance.
